ArticleFrontiers in oncology2022

Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways.

Giannis Mountzios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.